Bioactive peptides also induce the release of incretin hormones including glucagon‐like peptide‐1 (GLP‐1) and glucose-dependent insulinotropic polypeptide (GIP) that play a significant role in the enhancement of insulin resistance [96]. The gene discussed is GIP; the disease is Insulin resistance.